{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:13:40Z","timestamp":1793643220482,"version":"4.5.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["21707096"],"award-info":[{"award-number":["21707096"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YFS0127"],"award-info":[{"award-number":["2021YFS0127"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010032","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["20PJ075"],"award-info":[{"award-number":["20PJ075"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The optimal management of patients in reproductive endocrinology relies on the accuracy and validity of sex hormone assays. Endogenous or exogenous substances can compete with the analyte. This competition can result in interfering errors and falsely indicate elevated serum levels. Obvious interference in estradiol assays appears to occur rarely. Consequently, clinicians who are not familiar with the potential of interference could be misled. In addition to unnecessary investigations and interventions and severe mental stress, falsely elevated estradiol results can result in missed or delayed fertility opportunities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case<\/jats:title>\n                <jats:p>A 28-year-old female with pregnancy demand was diagnosed with polycystic ovary syndrome, Hashimoto\u2019s thyroiditis and subclinical hypothyroidism. She was found to have persistently elevated levels of serum estradiol in the early follicular phase (between 527 and 642 pg\/mL). Screening workup was performed for nearly 11 months to find the causes. Serum tumor biomarkers were normal. Abdominal and pelvic computed tomography were negative for adrenal or adnexal masses. A left mesosalpinx cyst and benign pathological results were achieved by laparoscopic surgery. Hormonal substances and dietary supplements were absent, as determined by dietary records. Ultrasound confirmed follicles could grow slowly and eventually ovulate. Falsely elevated estradiol levels were suspected due to the discrepancy among high estradiol levels, follicle growth and normal gonadotropin levels. Immunological interference by heterophile antibody was finally verified by two competitive chemiluminescent immunoassay platforms (estradiol levels in the early follicle phase: 619 pg\/mL, Siemens ADVIA CENTAUR and 60 pg\/mL, Beckman, DxI 800). Successful clinical pregnancy was eventually achieved by combining induced ovulation, ultrasound monitoring and intercourse guidance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Analytical interference and laboratory error should be suspicious at first when the clinical characteristics contradict the laboratory results of serum hormones. Measuring serum estradiol with another immunoassay platform is an easy and non-time-consuming method to exclude the heterophile interfering.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-01828-5","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:12:57Z","timestamp":1655381577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Falsely elevated serum estradiol in woman of reproductive age led to unnecessary intervention and delayed fertility opportunity: a case report and literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1978-0030","authenticated-orcid":false,"given":"Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"1828_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1258\/acb.2011.011073","volume":"48","author":"CM Sturgeon","year":"2011","unstructured":"Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin B Biochem. 2011;48:418\u201332.","journal-title":"Ann Clin B Biochem"},{"key":"1828_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","volume":"27","author":"N Bolstad","year":"2013","unstructured":"Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013;27:647\u201361.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1828_CR3","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.1016\/j.plabm.2019.e00131","volume":"17","author":"AS Maharjan","year":"2019","unstructured":"Maharjan AS, Wyness SP, Ray JA, Willcox TL, Seiter JD, Genzen JR. Detection and characterization of estradiol (E2) and unconjugated estriol (uE3) immunoassay interference due to anti-bovine alkaline phosphatase (ALP) antibodies. Pract Lab Med. 2019;17:e00131.","journal-title":"Pract Lab Med"},{"key":"1828_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0004563216674031","volume":"54","author":"S Mandic","year":"2017","unstructured":"Mandic S, Kratzsch J, Mandic D, et al. Falsely elevated serum oestradiol due to exemestane therapy. Ann Clin Biochem. 2017;54:402\u20135.","journal-title":"Ann Clin Biochem"},{"key":"1828_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41416-019-0378-9","volume":"120","author":"LJ Owen","year":"2019","unstructured":"Owen LJ, Monaghan PJ, Armstrong A, et al. Oestradiol measurement during fulvestrant treatment for breast cancer. Br J Cancer. 2019;120:404\u20136.","journal-title":"Br J Cancer"},{"key":"1828_CR6","volume-title":"Biotin and other interferences in immunoassays: a concise guide","author":"A Dasgupta","year":"2019","unstructured":"Dasgupta A. Biotin and other interferences in immunoassays: a concise guide. Amsterdam: Elsevier; 2019."},{"key":"1828_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000292323","volume":"40","author":"JH Check","year":"1995","unstructured":"Check JH, Ubelacker L, Lauer CC. Falsely elevated steroidal assay levels related to heterophile antibodies against various animal species. Gynecol Obstet Invest. 1995;40:139\u201340.","journal-title":"Gynecol Obstet Invest"},{"key":"1828_CR8","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1093\/humrep\/14.11.2724","volume":"14","author":"KJ Kairemo","year":"1999","unstructured":"Kairemo KJ, Kahn JA, Taipale PJ. Monoclonal gammopathy may disturb oestradiol measurement in the treatment and monitoring of in-vitro fertilization: case report. Hum Reprod. 1999;14:2724\u20136.","journal-title":"Hum Reprod"},{"key":"1828_CR9","doi-asserted-by":"publisher","first-page":"1822.e5-8","DOI":"10.1016\/j.fertnstert.2005.11.061","volume":"85","author":"E Anckaert","year":"2006","unstructured":"Anckaert E, Platteau P, Schiettecatte J, Devroey P, Van Steirteghem A, Smitz J. Spuriously elevated serum estradiol concentrations measured by an automated immunoassay rarely cause unnecessary cancellation of in vitro fertilization cycles. Fertil Steril. 2006;85:1822.e5-8.","journal-title":"Fertil Steril"},{"key":"1828_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4158\/EP.5.2.80","volume":"5","author":"DL Gordon","year":"1999","unstructured":"Gordon DL, Holmes E, Kovacs EJ, Brooks MH. A spurious markedly increased serum estradiol level due to an IgA lambda. Endocr Pract. 1999;5:80\u20133.","journal-title":"Endocr Pract"},{"key":"1828_CR11","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000324","author":"P Atkins","year":"2021","unstructured":"Atkins P, Mattman A, Thompson D. Falsely elevated serum estradiol due to heterophile antibody interference: a case report. Arch Endocrinol Metab. 2021. https:\/\/doi.org\/10.20945\/2359-3997000000324.","journal-title":"Arch Endocrinol Metab"},{"key":"1828_CR12","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1210\/js.2017-00191","volume":"1","author":"F Langlois","year":"2017","unstructured":"Langlois F, Moramarco J, He G, Carr BR. Falsely elevated steroid hormones in a postmenopausal woman due to laboratory interference. J Endocr Soc. 2017;1:1062\u20136.","journal-title":"J Endocr Soc"},{"key":"1828_CR13","first-page":"588","volume":"28","author":"S Li","year":"2019","unstructured":"Li S, Wang L, Chen S, et al. Falsely elevated serum estradiol concentration due to laboratory interference: two cases report and literature review. Shengzhi Yixue Zazhi. 2019;28:588\u201392.","journal-title":"Shengzhi Yixue Zazhi"},{"key":"1828_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00404-018-4906-2","volume":"298","author":"R Di Paola","year":"2018","unstructured":"Di Paola R, Garzon S, Giuliani S, et al. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman\u2019s age and markers of ovarian reserve. Arch Gynecol Obstet. 2018;298:1029\u201335.","journal-title":"Arch Gynecol Obstet"},{"key":"1828_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/jcm9040987","volume":"9","author":"S Davinelli","year":"2020","unstructured":"Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R. Targeting metabolic consequences of insulin resistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals: a focused review. J Clin Med. 2020;9:987.","journal-title":"J Clin Med"},{"key":"1828_CR16","doi-asserted-by":"publisher","first-page":"662582","DOI":"10.3389\/fendo.2021.662582","volume":"12","author":"S Benvenga","year":"2021","unstructured":"Benvenga S, Nordio M, Lagan\u00e0 AS, Unfer V. The role of inositol in thyroid physiology and in subclinical hypothyroidism management. Front Endocrinol (Lausanne). 2021;12:662582.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01828-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01828-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01828-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:14:41Z","timestamp":1655381681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01828-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01828-5","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"24 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This investigation received the approval (2021, No. 148) of the Ethical Committee of West China Second University Hospital, Sichuan University. Written informed consent was obtained from the patient to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}